Interferon-α-induced depressive symptoms are related to changes in the cytokine network but not to cortisol

Journal of Psychosomatic Research

Volumn 62, Issue 2, 2007, Pages 207-214

  Wichers, Marieke C ^a   Kenis, Gunter ^a   Koek, Ger H ^b   Robaeys, Geert ^c   Nicolson, Nancy A ^a   Maes, Michael ^d  

^a Department of Psychiatry and Neuropsychology   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d MCare4U Outpatient Clinics   (Belgium)

Author keywords

Cortisol; Depression; HPA axis; Interferon treatment; Proinflammatory cytokines

Indexed keywords

ALPHA INTERFERON; BENZODIAZEPINE; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 6; METHADONE; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HEPATITIS C; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PROTEIN BLOOD LEVEL; SALIVA ANALYSIS; TREATMENT OUTCOME;

ADULT; CYTOKINES; DEPRESSION; FEMALE; HEPATITIS C; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846491758     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.09.007     Document Type: Article

References (45)

1. Capuron L., and Miller A. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56 (2004) 819-824
2. Dieperink E., Ho S., Thuras P., and Willenbring M. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 44 (2003) 104-112
3. Bonaccorso S., Marino V., Puzella A., et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22 (2002) 86-90
4. Hauser P., Khosla J., Aurora H., et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 7 (2002) 942-947
5. Musselman D., Lawson D., Gumnick J., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344 (2001) 961-966
6. Taylor J., and Grossberg S. The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol 25 1 Suppl 1 (1998) 23-29
7. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 11-38
8. Sluzewska A., Rybakowski J., Bosmans E., et al. Indicators of immune activation in major depression. Psychiatry Res 64 (1996) 161-167
9. Mikova O., Yakimova R., Bosmans E., Kenis G., and Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11 (2001) 203-208
10. Zorrilla E., Luborsky L., McKay J., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15 (2001) 199-226
11. John C., and Buckingham J. Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis. Curr Opin Pharmacol 3 (2003) 78-84
12. Turnbull A., and Rivier C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
13. Miller D., and O'Callaghan J. Neuroendocrine aspects of the response to stress. Metabolism 51 6 Suppl 1 (2002) 5-10
14. Gisslinger H., Svoboda T., Clodi M., et al. Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57 (1993) 489-495
15. Muller H., Hammes E., Hiemke C., and Hess G. Interferon-alpha-2-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54 (1991) 499-503
16. Barbarino A., Colasanti S., Corsello S., et al. Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome. J Clin Endocrinol Metab 80 (1995) 1329-1332
17. Shimizu H., Ohtani K., Sato N., Nagamine T., and Mori M. Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration. Endocr J 42 (1995) 551-556
18. Swaab D., Bao A., and Lucassen P. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4 (2005) 141-194
19. Nemeroff C., Widerlov E., Bissette G., et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1344
20. Holsboer F., Gerken A., von Bardeleben U., et al. Human corticotropin-releasing hormone in depression-correlation with thyrotropin secretion following thyrotropin-releasing hormone. Biol Psychiatry 21 (1986) 601-611
21. Gold P., Loriaux D., Roy A., et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 314 (1986) 1329-1335
22. Maes M., Lin A., Bonaccorso S., et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98 (1998) 328-335
23. Deuschle M., Weber B., Colla M., Depner M., and Heuser I. Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress 2 (1998) 281-287
24. Pruessner M., Hellhammer D., Pruessner J., and Lupien S. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom Med 65 (2003) 92-99
25. Bhagwagar Z., Hafizi S., and Cowen P. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry 160 (2003) 1890-1891
26. Carroll B., Curtis G., and Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 33 (1976) 1039-1044
27. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
28. Miller A., Pariante C., and Pearce B. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 461 (1999) 107-116
29. Rowe W., Steverman A., Walker M., et al. Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats. Neurobiol Aging 18 (1997) 527-533
30. Wichers M., Koek G., Robaeys G., Praamstra A., and Maes M. Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med 34 (2005) 433-441
31. Brok J., Gluud L., and Gluud C. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials. Arch Intern Med 165 (2005) 2206-2212
32. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
33. Montgomery S., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
34. Gunnar M., Morison S., Chisholm K., and Schuder M. Salivary cortisol levels in children adopted from Romanian orphanages. Dev Psychopathol 13 (2001) 611-628
35. Pruessner J., Kirschbaum C., Meinlschmid G., and Hellhammer D. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
36. Schmidt-Reinwald A., Pruessner J., Hellhammer D., et al. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci 64 (1999) 1653-1660
37. Clow A., Thorn L., Evans P., and Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 7 (2004) 29-37
38. Bonaccorso S., Puzella A., Marino V., et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 105 (2001) 45-55
39. Oppenheim J., Ruscetti F., and Faltynek C. Cytokines. In: Stites D., Terr A., and Parslow T. (Eds). Basis & clinical immunology (1994), Appleton & Lange, Stamford, Connecticut 870
40. Capuron L., Raison C., Musselman D., Lawson D., Nemeroff C., and Miller A. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160 (2003) 1342-1345
41. Cassidy E., Manning D., Byrne S., et al. Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6. J Psychopharmacol 16 (2002) 230-234
42. Roberts A., Wessely S., Chalder T., Papadopoulos A., and Cleare A. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 184 (2004) 136-141
43. Martins J., Alves J., Trinca A., et al. Personality, brain asymmetry, and neuroendocrine reactivity in two immune-mediated disorders: a preliminary report. Brain Behav Immun 16 (2002) 383-397
44. Hultgren C., Milich D., Weiland O., and Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 79 Pt 10 (1998) 2381-2391
45. Kunz-Ebrecht S., Kirschbaum C., Marmot M., and Steptoe A. Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort. Psychoneuroendocrinology 29 (2004) 516-528